GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » 3-Year Dividend Growth Rate

Natco Pharma (BOM:524816) 3-Year Dividend Growth Rate : 15.00% (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma 3-Year Dividend Growth Rate?

Natco Pharma's Dividends per Share for the three months ended in Mar. 2024 was ₹1.25.

The historical rank and industry rank for Natco Pharma's 3-Year Dividend Growth Rate or its related term are showing as below:

BOM:524816' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -8.8   Med: 16.5   Max: 102.1
Current: 15

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Natco Pharma was 102.10% per year. The lowest was -8.80% per year. And the median was 16.50% per year.

BOM:524816's 3-Year Dividend Growth Rate is ranked worse than
80.95% of 315 companies
in the Drug Manufacturers industry
Industry Median: 10.4 vs BOM:524816: 15.00

During the past 12 months, Natco Pharma's average Dividends Per Share Growth Rate was 72.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 15.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 21.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Natco Pharma's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.06. As of today, Natco Pharma's Dividend Yield % is 0.92%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Natco Pharma's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natco Pharma's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Natco Pharma's 3-Year Dividend Growth Rate falls into.



Natco Pharma 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Natco Pharma  (BOM:524816) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Natco Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=1.25/ 21.56
=0.06

During the past 13 years, the highest Dividend Payout Ratio of Natco Pharma was 0.55. The lowest was 0.11. And the median was 0.18.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Natco Pharma Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 1.2500002024-02-262024-02-262024-03-04Cash DividendquarterlyINR:INR 1.000000
INR 1.2500002023-11-242023-11-242023-12-01Cash DividendquarterlyINR:INR 1.000000
INR 7.0000002023-08-222023-08-222023-08-30Cash DividendquarterlyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Natco Pharma's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=9.5/1040.90
=0.91 %

Current Share Price is ₹1040.90.
Natco Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹9.5.

During the past 13 years, the highest Dividend Yield of Natco Pharma was 1.50%. The lowest was 0.17%. And the median was 0.72%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Natco Pharma 3-Year Dividend Growth Rate Related Terms>


Natco Pharma (BOM:524816) Business Description

Traded in Other Exchanges
Address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines